A Two-part Single and Multiple Dose Study to Assess the Safety , Pharmacokinetics and Effects of AZD3293 in Healthy Japanese Young and Elderly Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Healthy Japanese Young and Elderly Male and Non-fertile Female Volunteers
Interventions
DRUG

AZD3293

Oral solution

DRUG

Placebo

Oral solution

Trial Locations (1)

Unknown

Research Site, Fukuoka

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY